GW Henssler & Associates’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-3,417
Closed -$247K – 215
2023
Q1
$247K Buy
3,417
+37
+1% +$2.9K 0.02% 191
2022
Q4
$271K Hold
3,380
– – 0.02% 181
2022
Q3
$225K Buy
3,380
+494
+17% +$36.5K 0.02% 195
2022
Q2
$219K Buy
+2,886
New +$219K 0.02% 195

Other funds holding INCY

GW Henssler & Associates's INCY Position: Q2 2023 in Review

GW Henssler & Associates sold out of Incyte (INCY) in Q2 2023, closing a stake of 3,417 shares — an estimated $247K sold.

GW Henssler & Associates first reported a position in INCY in Q2 2022 and held it in 4 quarters. The position peaked at $271K in Q4 2022. 527 funds tracked by Wall St. Rank hold INCY as of Q2 2023.

  • GW Henssler & Associates reported no remaining Incyte position as of Q2 2023 after selling out during the quarter.
  • GW Henssler & Associates sold 3,417 Incyte shares in Q2 2023, an estimated $247K.
  • GW Henssler & Associates first reported a position in Incyte in Q2 2022 and held it in 4 quarters.
  • GW Henssler & Associates's Incyte position peaked at $271K in Q4 2022.
  • 527 funds tracked by Wall St. Rank held Incyte as of Q2 2023.

Based on GW Henssler & Associates's 13F filing for Q2 2023, filed 2 Aug 2023.